HbA1c Testing Market Research Report - Global Forecast till 2027

Global HbA1c Testing  Market: Information by Product (Instruments (Bench-Top Device and Handheld Device) and Reagents and Kits), By Technology (Ion-Exchange High-Performance Liquid Chromatography (HPLC), Turbidimetric Inhibition Immunoassay (TINIA), Enzymatic Assay and Others), By End User (Hospitals and Clinics, Diagnostic Laboratories and Others) and by Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2027

ID: MRFR/HC/7045-CR | October 2019 | Region: Global | 134 pages

Please note that the assessment period of report has been updated from 2018-2025 to 2020-2027. Cordially fill the sample form for updated data.

Market Overview HbA1c Testing Market is expected to register a CAGR of 12.24% to reach USD 1,992.44 Million by 2025. Hemoglobin A1c (HbA1c) is a form of hemoglobin that is bound to glucose. The HbA1c test provides the patient with the average level of blood sugar only for the past 2 to 3 months.


Market Dynamics


Diabetes has become one of the most prevalent epidemics across the world, and among the three types of diabetes, type 2 diabetes is the most common. According to a research paper published by the National Center for Biotechnology Information (NCBI) in September 2016, diabetes is anticipated to be the seventh leading cause of death by 2030. Moreover, according to data published by the International Diabetes Federation in 2017, the prevalence of diabetes in Brazil was 8.7% among adults and reported 12,465,800 cases of diabetes in 2017. These increasing occurrences push for various testing methods such as HbA1c testing in patients for diagnosis. Therefore, this factor is supporting the market growth of the global HbA1c testing market.


Global HbA1c Testing Market Share, by End User, 2018 (%)  HbA1c Testing Market


Source: MRFR Analysis


Segmentation


The global HbA1c testing market has been segmented by product, technology, and end user.


The market, based on product, has been bifurcated into reagents and kits and instruments. The market, based on instruments, has been further segmented into a bench-top device and handheld device.


Based on technology, the HbA1c testing market has been segregated into ion-exchange HPLC, enzymatic assay, TINIA, and others. The global HbA1c testing market, based on end user, has been divided into hospitals and clinics, diagnostic laboratories, and others.


Americas HbA1c Testing Market Share, 2018 (%)  HbA1c Testing Market


Source: MRFR Analysis


Regional Analysis


The Global HbA1c Testing Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.


The Americas is likely to dominate the global HbA1c testing market. This can be attributed to growing activities such as research, awareness campaigns, and joint ventures by public and private organizations in the US and Canada.


The European market for HbA1c testing is expected to be the second-largest during the review period. Their growing adoption of advanced diagnostic tools and devices coupled with the strategic activities such as partnerships and agreements by the prominent players is expected to boost the growth of the regional market.


Asia-Pacific is estimated to be the fastest-growing market owing to the developing healthcare infrastructure and increasing per capita disposable incomes.


The market in the Middle East & Africa is expected to witness steady growth due to limited access to healthcare. The growing awareness regarding healthcare and the availability of new advanced treatment options are factors expected to drive the growth of the market in the region.


Key Players


The Prominent Players in the Global HbA1c Testing Market are Abbott Laboratories (US), Bio-Rad Laboratories, Inc. (US), ARKRAY, Inc. (Japan), F. Hoffmann-La Roche Ltd (Switzerland), Danaher Corporation (US), Siemens Healthineers (US), Transasia Bio-Medicals (India), EKF Diagnostics (UK), Agappe Diagnostics Ltd (India), PTS Diagnostics (US), DiaSys Diagnostic Systems GmbH (Germany), CPC Diagnostics Pvt. Ltd. (India), Trinity Biotech PLC (Ireland), Rapid Diagnostics Group of Companies (India), and Tosoh India Pvt. Ltd. (India), .


Some of the key strategies followed by players operating in the global HbA1c testing market were innovation, product development, and acquisition & mergers.



  • In January 2019, EKF Diagnostics launched DiaSpect Tm Hb analyzer in the US. It is the world’s fastest hemoglobin analyzer and is used for the diagnosis of various disorders. Hence, this product launch increased the revenue of the company.



  • In December 2018, Siemens Healthineers acquired Fast-Track Diagnostics (FTD). FTD is a global supplier of molecular diagnostic test kits. This deal will improve patient experience and develop precision medicine.



  • In June 2017, ARKRAY, Inc. acquired HDK Philippines Inc. and established ARKRAY Industry West, Inc. in the country. It helped the company expand its operations in the Philippines.


Market Segmentation


Global HbA1c Testing Market, by Product



  • Instruments

    • Bench-Top Device

    • Handheld Device



  • Reagents and Kits


Global HbA1c Testing Market, by Technology



  • Ion-Exchange HPLC

  • Enzymatic Assay

  • TINIA

  • Others


Global HbA1c Testing Market, by End User



  • Hospitals and Clinics

  • Diagnostic Laboratories

  • Others


Global HbA1c Testing Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • Latin America





  • Europe

    • Western Europe

      • Germany

      • UK

      • France

      • Italy

      • Spain

      • Rest of Western Europe



    • Eastern Europe





  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific





  • Middle East & Africa

    • Middle East

    • Africa




Available Additional Customizations



  • Mega Trends in the Market

  • HbA1c Testing Company Profiles:

    • Zivak Technologies

    • Erba Group

    • OSANG Healthcare

    • Meril Life Sciences Pvt. Ltd




Intended Audience



  • Pharmaceutical companies

  • Research & development organizations

  • Academic institutes



Report Scope:
Report Attribute/Metric Details
  Market Size   USD 1,992.44 Million
  CAGR   12.24% (2018-2025)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Product, Technology and End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Abbott Laboratories (US), Bio-Rad Laboratories, Inc. (US), ARKRAY, Inc. (Japan), F. Hoffmann-La Roche Ltd (Switzerland), Danaher Corporation (US), Siemens Healthineers (US), Transasia Bio-Medicals (India), EKF Diagnostics (UK), Agappe Diagnostics Ltd (India), PTS Diagnostics (US), DiaSys Diagnostic Systems GmbH (Germany), CPC Diagnostics Pvt. Ltd. (India), Trinity Biotech PLC (Ireland), Rapid Diagnostics Group of Companies (India), and Tosoh India Pvt. Ltd. (India)
  Key Market Opportunities   Growing adoption of advanced diagnostic tools and devices coupled with the strategic activities such as partnerships and agreements by the prominent players
  Key Market Drivers

  • Developing healthcare infrastructure and increasing per capita disposable incomes
  • Availability of new advanced treatment options


  • Frequently Asked Questions (FAQ) :


    HbA1c Testing Market is projected to grow at a 12.24% CAGR between 2016-2025.

    The Americas is expected to dominate the HbA1c Testing Market.

    HbA1c Testing Market is predicted to touch USD 1,992.44 million by 2025.

    The hospitals and clinics segment will lead the HbA1c Testing Market.

    The reagents & kits segment will dominate the HbA1c Testing Market.

    1 Executive Summary

    1.1 MARKET SYNOPSIS 14

    1.2 MARKET ATTRACTIVENESS ANALYSIS 15

    1.3 GLOBAL HBA1C TESTING MARKET, BY PRODUCT 16

    1.4 GLOBAL HBA1C TESTING MARKET, BY TECHNOLOGY 17

    1.5 GLOBAL HBA1C TESTING MARKET, BY END USER 18

    2 Market Introduction

    2.1 DEFINITION 19

    2.2 SCOPE OF THE STUDY 19

    2.3 RESEARCH OBJECTIVE 19

    2.4 MARKET STRUCTURE 20

    2.5 ASSUMPTIONS & LIMITATIONS 20

    3 Research Methodology

    3.1 DATA MINING 21

    3.2 SECONDARY RESEARCH 22

    3.3 PRIMARY RESEARCH 23

    3.4 BREAKDOWN OF PRIMARY RESPONDENTS 24

    3.5 FORECASTING TECHNIQUES 25

    3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 26

    3.6.1 BOTTOM-UP APPROACH 27

    3.6.2 TOP-DOWN APPROACH 27

    3.7 DATA TRIANGULATION 28

    3.8 VALIDATION 28

    4 MARKET DYNAMICS

    4.1 OVERVIEW 29

    4.2 DRIVERS 30

    4.2.1 RISING PREVALENCE OF DIABETES 30

    4.2.2 INCREASING INITIATIVES BY KEY PLAYERS 30

    4.2.3 GROWING NUMBER OF RESEARCH ORGANIZATIONS AND ASSOCIATIONS FOR DIABETES 30

    4.2.4 INCREASING GERIATRIC POPULATION AND THE INFLUENCE OF SEDENTARY LIFESTYLE AND UNHEALTHY DIET 30

    4.3 RESTRAINTS 32

    4.3.1 LIMITED INDICATIONS OF HBA1C TESTS 32

    4.3.2 STRINGENT REIMBURSEMENT POLICIES IN DEVELOPING COUNTRIES 32

    4.4 OPPORTUNITIES 33

    4.4.1 INCREASING APPROVALS AND PRODUCT LAUNCHES 33

    4.4.2 INCORPORATION OF VARIOUS TECHNOLOGIES IN HBA1C TESTING INSTRUMENTS 33

    5 MARKET FACTOR ANALYSIS

    5.1 PORTER’S FIVE FORCES MODEL 34

    5.1.1 THREAT OF NEW ENTRANTS 34

    5.1.2 BARGAINING POWER OF SUPPLIERS 35

    5.1.3 THREAT OF SUBSTITUTES 35

    5.1.4 BARGAINING POWER OF BUYERS 35

    5.1.5 INTENSITY OF RIVALRY 35

    5.2 VALUE CHAIN ANALYSIS 36

    5.2.1 R&D AND DESIGNING 37

    5.2.2 MANUFACTURING 37

    5.2.3 DISTRIBUTION 37

    5.2.4 MARKETING & SALES 37

    5.2.5 POST-SALES MONITORING 37

    6 HBA1C TESTING MARKET, BY PRODUCT

    6.1 OVERVIEW 38

    6.2 REAGENTS & KITS 39

    6.3 INSTRUMENTS 40

    6.3.1 BENCH-TOP DEVICE 41

    6.3.2 HANDHELD DEVICE 42

    7 HBA1C TESTING MARKET, BY TECHNOLOGY

    7.1 OVERVIEW 43

    7.2 ION-EXCHANGE HPLC 44

    7.3 ENZYMATIC ASSAY 45

    7.4 TURBIDIMETRIC INHIBITION IMMUNOASSAY (TINIA) 46

    7.5 OTHERS 46

    8 HBA1C TESTING MARKET, BY END USER

    8.1 OVERVIEW 47

    8.2 HOSPITALS AND CLINICS 48

    8.3 DIAGNOSTIC LABORATORIES 49

    8.4 OTHERS 49

    9 GLOBAL HBA1C TESTING MARKET, BY REGION

    9.1 OVERVIEW 50

    9.2 AMERICAS 52

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    9.2.1 OVERVIEW 52

    9.2.2 NORTH AMERICA 55

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    9.2.2.1 US 58

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    9.2.2.2 CANADA 60

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    9.2.3 LATIN AMERICA 62

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    9.3 EUROPE 64

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    9.3.1 OVERVIEW 64

    9.3.2 WESTERN EUROPE 67

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    9.3.2.1 UK 70

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    9.3.2.2 GERMANY 72

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    9.3.2.3 FRANCE 74

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    9.3.2.4 ITALY 76

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    9.3.2.5 SPAIN 78

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    9.3.2.6 REST OF WESTERN EUROPE 80

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    9.3.3 EASTERN EUROPE 82

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    9.4 ASIA-PACIFIC 84

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    9.4.1 OVERVIEW 84

    9.4.2 CHINA 87

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    9.4.3 INDIA 89

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    9.4.4 JAPAN 91

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    9.4.5 SOUTH KOREA 93

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    9.4.6 AUSTRALIA 95

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    9.4.7 REST OF ASIA-PACIFIC 97

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    9.5 MIDDLE EAST & AFRICA 99

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    9.5.1 OVERVIEW 99

    9.5.2 MIDDLE EAST 102

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    9.5.3 AFRICA 104

    HBA1C TESTING MARKET, BY PRODUCT

    HBA1C TESTING MARKET, BY TECHNOLOGY

    HBA1C TESTING MARKET, BY END USER

    10 COMPETITIVE LANDSCAPE

    10.1 OVERVIEW 106

    10.2 COMPANY SHARE ANALYSIS, 2020 (%) 106

    11 COMPANY PROFILES

    11.1 ABBOTT LABORATORIES 108

    11.1.1 COMPANY OVERVIEW 108

    11.1.2 FINANCIAL OVERVIEW 108

    11.1.3 PRODUCTS/SERVICES OFFERED 109

    11.1.4 ABBOTT LABORATORIES: KEY DEVELOPMENTS 109

    11.1.5 SWOT ANALYSIS 109

    11.1.6 KEY STRATEGIES 110

    11.2 BIO-RAD LABORATORIES, INC. 111

    11.2.1 COMPANY OVERVIEW 111

    11.2.2 FINANCIAL OVERVIEW 111

    11.2.3 PRODUCTS/SERVICES OFFERED 112

    11.2.4 KEY DEVELOPMENTS 112

    11.2.5 SWOT ANALYSIS 113

    11.2.6 KEY STRATEGIES 113

    11.3 DANAHER CORPORATION 114

    11.3.1 COMPANY OVERVIEW 114

    11.3.2 FINANCIAL OVERVIEW 114

    11.3.3 PRODUCTS/SERVICES OFFERED 115

    11.3.4 KEY DEVELOPMENTS 115

    11.3.5 SWOT ANALYSIS 115

    11.3.6 KEY STRATEGIES 115

    11.4 F. HOFFMANN-LA ROCHE LTD 116

    11.4.1 COMPANY OVERVIEW 116

    11.4.2 FINANCIAL OVERVIEW 116

    11.4.3 PRODUCTS/SERVICES OFFERED 117

    11.4.4 KEY DEVELOPMENTS 117

    11.4.5 SWOT ANALYSIS 117

    11.4.6 KEY STRATEGIES 118

    11.5 SIEMENS HEALTHINEERS 119

    11.5.1 COMPANY OVERVIEW 119

    11.5.2 FINANCIAL OVERVIEW 119

    11.5.3 PRODUCTS/SERVICES OFFERED 120

    11.5.4 KEY DEVELOPMENTS 120

    11.5.5 SWOT ANALYSIS 120

    11.5.6 KEY STRATEGIES 121

    11.6 EKF DIAGNOSTICS 122

    11.6.1 COMPANY OVERVIEW 122

    11.6.2 FINANCIAL OVERVIEW 122

    11.6.3 PRODUCTS/SERVICES OFFERED 123

    11.6.4 KEY DEVELOPMENTS 123

    11.6.5 SWOT ANALYSIS 123

    11.6.6 KEY STRATEGIES 124


    11.7 ARKRAY, INC. 125

    11.7.1 COMPANY OVERVIEW 125

    11.7.2 ARKRAY, INC.: FINANCIAL OVERVIEW 125

    11.7.3 PRODUCTS/SERVICES OFFERED 125

    11.7.4 KEY DEVELOPMENTS 125

    11.7.5 SWOT ANALYSIS 126

    11.7.6 KEY STRATEGIES 126

    11.8 TRINITY BIOTECH PLC. 127

    11.8.1 COMPANY OVERVIEW 127

    11.8.2 FINANCIAL OVERVIEW 127

    11.8.3 PRODUCTS/SERVICES OFFERED 128

    11.8.4 KEY DEVELOPMENTS 128

    11.8.5 SWOT ANALYSIS 128

    11.8.6 KEY STRATEGIES 128

    11.9 PTS DIAGNOSTICS 129

    11.9.1 COMPANY OVERVIEW 129

    11.9.2 FINANCIAL OVERVIEW 129

    11.9.3 PRODUCTS/SERVICES OFFERED 129

    11.9.4 KEY DEVELOPMENTS 129

    11.9.5 SWOT ANALYSIS 130

    11.9.6 KEY STRATEGIES 130

    11.10 DIASYS DIAGNOSTIC SYSTEMS GMBH 131

    11.10.1 COMPANY OVERVIEW 131

    11.10.2 FINANCIAL OVERVIEW 131

    11.10.3 PRODUCTS/SERVICES OFFERED 131

    11.10.4 KEY DEVELOPMENTS 131

    11.10.5 SWOT ANALYSIS 132

    11.10.6 KEY STRATEGIES 132

    12 APPENDIX

    12.1 REFERENCES 133

    12.2 RELATED REPORTS 133

    13 List of Tables

    TABLE 1 LIST OF ASSUMPTIONS 20

    TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 24

    TABLE 3 GLOBAL HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 39

    TABLE 4 GLOBAL HBA1C TESTING MARKET FOR INSTRUMENTS, BY REGION, 2020–2027 (USD MILLION) 40

    TABLE 5 GLOBAL HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 40

    TABLE 6 GLOBAL HBA1C TESTING MARKET FOR INSTRUMENTS, BY REGION, 2020–2027 (USD MILLION) 41

    TABLE 7 GLOBAL HBA1C TESTING MARKET FOR BENCH-TOP DEVICE, BY REGION, 2020–2027 (USD MILLION) 41

    TABLE 8 GLOBAL HBA1C TESTING MARKET FOR HANDHELD DEVICE, BY REGION, 2020–2027 (USD MILLION) 42

    TABLE 9 GLOBAL HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 44

    TABLE 10 GLOBAL HBA1C TESTING MARKET FOR ION-EXCHANGE HPLC, BY REGION, 2020–2027 (USD MILLION) 45

    TABLE 11 GLOBAL HBA1C TESTING MARKET FOR ENZYMATIC ASSAY, BY REGION, 2020–2027 (USD MILLION) 45

    TABLE 12 GLOBAL HBA1C TESTING MARKET FOR TURBIDIMETRIC INHIBITION IMMUNOASSAY (TINIA), BY REGION,

    2020–2027 (USD MILLION) 46

    TABLE 13 GLOBAL HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 48

    TABLE 14 GLOBAL HBA1C TESTING MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2020–2027 (USD MILLION) 48

    TABLE 15 GLOBAL HBA1C TESTING MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2020–2027 (USD MILLION) 49

    TABLE 16 GLOBAL HBA1C TESTING MARKET, BY REGION, 2020–2027 (USD MILLION) 51

    TABLE 17 AMERICAS: HBA1C TESTING MARKET, BY REGION, 2020–2027 (USD MILLION) 53

    TABLE 18 AMERICAS: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 53

    TABLE 19 AMERICAS: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 53

    TABLE 20 AMERICAS: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 54

    TABLE 21 AMERICAS: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 54

    TABLE 22 NORTH AMERICA: HBA1C TESTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 55

    TABLE 23 NORTH AMERICA: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 56

    TABLE 24 NORTH AMERICA: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 56

    TABLE 25 NORTH AMERICA: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 57

    TABLE 26 NORTH AMERICA: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 57

    TABLE 27 US: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 58

    TABLE 28 US: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 58

    TABLE 29 US: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 59

    TABLE 30 US: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 59

    TABLE 31 CANADA: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 60

    TABLE 32 CANADA: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 60

    TABLE 33 CANADA: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 61

    TABLE 34 CANADA: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 61

    TABLE 35 LATIN AMERICA: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 62

    TABLE 36 LATIN AMERICA: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 62

    TABLE 37 LATIN AMERICA: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 63

    TABLE 38 LATIN AMERICA: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 63

    TABLE 39 EUROPE: HBA1C TESTING MARKET, BY REGION, 2020–2027 (USD MILLION) 64

    TABLE 40 EUROPE: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 65

    TABLE 41 EUROPE: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 65

    TABLE 42 EUROPE: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 66

    TABLE 43 EUROPE: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 66

    TABLE 44 WESTERN EUROPE: HBA1C TESTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 67

    TABLE 45 WESTERN EUROPE: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 68

    TABLE 46 WESTERN EUROPE: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 68

    TABLE 47 WESTERN EUROPE: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 69

    TABLE 48 WESTERN EUROPE: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 69

    TABLE 49 UK: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 70

    TABLE 50 UK: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 70

    TABLE 51 UK: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 71

    TABLE 52 UK: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 71

    TABLE 53 GERMANY: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 72

    TABLE 54 GERMANY: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 72

    TABLE 55 GERMANY: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 73

    TABLE 56 GERMANY: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 73

    TABLE 57 FRANCE: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 74

    TABLE 58 FRANCE: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 74

    TABLE 59 FRANCE: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 75

    TABLE 60 FRANCE: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 75

    TABLE 61 ITALY: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 76

    TABLE 62 ITALY: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 76

    TABLE 63 ITALY: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 77

    TABLE 64 ITALY: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 77

    TABLE 65 SPAIN: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 78

    TABLE 66 SPAIN: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 78

    TABLE 67 SPAIN: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 79

    TABLE 68 SPAIN: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 79

    TABLE 69 REST OF WESTERN EUROPE: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 80

    TABLE 70 REST OF WESTERN EUROPE: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 80

    TABLE 71 REST OF WESTERN EUROPE: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 81

    TABLE 72 REST OF WESTERN EUROPE: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 81

    TABLE 73 EASTERN EUROPE: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 82

    TABLE 74 EASTERN EUROPE: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 82

    TABLE 75 EASTERN EUROPE: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 83

    TABLE 76 EASTERN EUROPE: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 83

    TABLE 77 ASIA-PACIFIC: HBA1C TESTING MARKET, BY COUNTRY,2020–2027 (USD MILLION) 84

    TABLE 78 ASIA-PACIFIC: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 85

    TABLE 79 ASIA-PACIFIC: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 85

    TABLE 80 ASIA-PACIFIC: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 86

    TABLE 81 ASIA-PACIFIC: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 86

    TABLE 82 CHINA: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 87

    TABLE 83 CHINA: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 87

    TABLE 84 CHINA: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 88

    TABLE 85 CHINA: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 88

    TABLE 86 INDIA: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 89

    TABLE 87 INDIA: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 89

    TABLE 88 INDIA: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 90

    TABLE 89 INDIA: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 90

    TABLE 90 JAPAN: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 91

    TABLE 91 JAPAN: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 91

    TABLE 92 JAPAN: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 92

    TABLE 93 JAPAN: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 92

    TABLE 94 SOUTH KOREA: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 93

    TABLE 95 SOUTH KOREA: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 93

    TABLE 96 SOUTH KOREA: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 94

    TABLE 97 SOUTH KOREA: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 94

    TABLE 98 AUSTRALIA: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 95

    TABLE 99 AUSTRALIA: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 95

    TABLE 100 AUSTRALIA: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 96

    TABLE 101 AUSTRALIA: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 96

    TABLE 102 REST OF ASIA-PACIFIC: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 97

    TABLE 103 REST OF ASIA-PACIFIC: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 97

    TABLE 104 REST OF ASIA-PACIFIC: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 98

    TABLE 105 REST OF ASIA-PACIFIC: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 98

    TABLE 106 MIDDLE EAST & AFRICA: HBA1C TESTING MARKET, BY REGION,2020–2027 (USD MILLION) 99

    TABLE 107 MIDDLE EAST & AFRICA: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 100

    TABLE 108 MIDDLE EAST & AFRICA: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 100

    TABLE 109 MIDDLE EAST & AFRICA: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 101

    TABLE 110 MIDDLE EAST & AFRICA: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 101

    TABLE 111 MIDDLE EAST: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 102

    TABLE 112 MIDDLE EAST: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 102

    TABLE 113 MIDDLE EAST: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 103

    TABLE 114 MIDDLE EAST: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 103

    TABLE 115 AFRICA: HBA1C TESTING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 104

    TABLE 116 AFRICA: HBA1C TESTING MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION) 104

    TABLE 117 AFRICA: HBA1C TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 105

    TABLE 118 AFRICA: HBA1C TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 105

    TABLE 119 ABBOTT LABORATORIES: PRODUCTS/SERVICES OFFERED 109

    TABLE 120 ABBOTT LABORATORIES: KEY DEVELOPMENTS 109

    TABLE 121 BIO-RAD LABORATORIES INC.: PRODUCTS/SERVICES OFFERED 112

    TABLE 122 BIO-RAD LABORATORIES, INC.: KEY DEVELOPMENTS 112

    TABLE 123 DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED 115

    TABLE 124 DANAHER CORPORATION: KEY DEVELOPMENTS 115

    TABLE 125 F. HOFFMANN-LA ROCHE LTD: PRODUCTS/SERVICES OFFERED 117

    TABLE 126 F. HOFFMANN-LA ROCHE LTD: KEY DEVELOPMENTS 117

    TABLE 127 SIEMENS HEALTHINEERS: PRODUCTS/SERVICES OFFERED 120

    TABLE 128 SIEMENS HEALTHINEERS: KEY DEVELOPMENTS 120

    TABLE 129 EKF DIAGNOSTICS PRODUCTS/SERVICES OFFERED 123

    TABLE 130 EKF DIAGNOSTICS KEY DEVELOPMENTS 123

    TABLE 131 ARKRAY, INC.: PRODUCTS/SERVICES OFFERED 125

    TABLE 132 ARKRAY, INC.: KEY DEVELOPMENTS 125

    TABLE 133 TRINITY BIOTECH PLC.: PRODUCTS/SERVICES OFFERED 128

    TABLE 134 PTS DIAGNOSTICS: PRODUCTS/SERVICES OFFERED 129

    TABLE 135 DIASYS DIAGNOSTIC SYSTEMS GMBH: PRODUCTS/SERVICES OFFERED 131

    14 List of Figures

    FIGURE 1 MARKET SYNOPSIS 14

    FIGURE 2 MARKET ATTRACTIVENESS ANALYSIS (2020) 15

    FIGURE 3 GLOBAL HBA1C TESTING MARKET ANALYSIS, BY PRODUCT 16

    FIGURE 4 GLOBAL HBA1C TESTING MARKET ANALYSIS, BY TECHNOLOGY 17

    FIGURE 5 GLOBAL HBA1C TESTING MARKET ANALYSIS, BY END USER 18

    FIGURE 6 GLOBAL HBA1C TESTING MARKET: STRUCTURE 20

    FIGURE 7 BOTTOM-UP AND TOP-DOWN APPROACHES 26

    FIGURE 8 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL HBA1C TESTING MARKET 29

    FIGURE 9 DRIVERS IMPACT ANALYSIS 31

    FIGURE 10 RESTRAINT IMPACT ANALYSIS 32

    FIGURE 11 PORTER’S FIVE FORCES ANALYSIS: GLOBAL HBA1C TESTING MARKET 34

    FIGURE 12 VALUE CHAIN ANALYSIS OF THE GLOBAL HBA1C TESTING MARKET 36

    FIGURE 13 GLOBAL HBA1C TESTING MARKET SHARE, BY PRODUCT, 2020 (%) 38

    FIGURE 14 GLOBAL HBA1C TESTING MARKET, BY PRODUCT, 2020 & 2027 (USD MILLION) 38

    FIGURE 15 GLOBAL HBA1C TESTING MARKET SHARE, BY TECHNOLOGY, 2020 (%) 43

    FIGURE 16 GLOBAL HBA1C TESTING MARKET, BY TECHNOLOGY, 2020 & 2027 (USD MILLION) 43

    FIGURE 17 GLOBAL HBA1C TESTING MARKET SHARE, BY END USER, 2020 (%) 47

    FIGURE 18 GLOBAL HBA1C TESTING MARKET, BY END USER, 2020 & 2027 (USD MILLION) 47

    FIGURE 19 GLOBAL HBA1C TESTING MARKET SHARE, BY REGION, 2020 (%) 50

    FIGURE 20 GLOBAL HBA1C TESTING MARKET, BY REGION, 2020 AND 2027 (USD MILLION) 50

    FIGURE 21 AMERICAS: HBA1C TESTING MARKET SHARE, BY REGION, 2020 (%) 52

    FIGURE 22 NORTH AMERICA: HBA1C TESTING MARKET SHARE, BY COUNTRY, 2020 (%) 55

    FIGURE 23 EUROPE: HBA1C TESTING MARKET SHARE, BY REGION, 2020 (%) 64

    FIGURE 24 WESTERN EUROPE: HBA1C TESTING MARKET SHARE, BY COUNTRY, 2020 (%) 67

    FIGURE 25 ASIA-PACIFIC: HBA1C TESTING MARKET SHARE, BY COUNTRY, 2020 (%) 84

    FIGURE 26 MIDDLE EAST & AFRICA: HBA1C TESTING MARKET SHARE, BY REGION, 2020 (%) 99

    FIGURE 27 GLOBAL HBA1C TESTING MARKET, MAJOR PLAYER MARKET SHARE ANALYSIS 2020 (%) 106

    FIGURE 28 INDIA HBA1C TESTING MARKET, MAJOR PLAYER MARKET SHARE ANALYSIS 2020 (%) 107

    FIGURE 29 ABBOTT LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT 108

    FIGURE 30 ABBOTT LABORATORIES: SWOT ANALYSIS 109

    FIGURE 31 BIO-RAD LABORATORIES, INC.: FINANCIAL OVERVIEW SNAPSHOT 111

    FIGURE 32 BIO-RAD LABORATORIES INC: SWOT ANALYSIS 113

    FIGURE 33 DANAHER CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 114

    FIGURE 34 DANAHER CORPORATION: SWOT ANALYSIS 115

    FIGURE 35 F. HOFFMANN-LA ROCHE LTD: FINANCIAL OVERVIEW SNAPSHOT 116

    FIGURE 36 F. HOFFMANN-LA ROCHE LTD: SWOT ANALYSIS 117

    FIGURE 37 SIEMENS: FINANCIAL OVERVIEW SNAPSHOT 119

    FIGURE 38 SIEMENS HEALTHINEERS: SWOT ANALYSIS 120

    FIGURE 39 EKF DIAGNOSTICS: FINANCIAL OVERVIEW SNAPSHOT 122

    FIGURE 40 EKF DIAGNOSTICS: SWOT ANALYSIS 123

    FIGURE 41 ARKRAY, INC.: SWOT ANALYSIS 126

    FIGURE 42 TRINITY BIOTECH PLC.: FINANCIAL OVERVIEW SNAPSHOT 127

    FIGURE 43 TRINITY BIOTECH PLC.: SWOT ANALYSIS 128

    FIGURE 44 PTS DIAGNOSTICS: SWOT ANALYSIS 130

    FIGURE 45 DIASYS DIAGNOSTIC SYSTEMS GMBH: SWOT ANALYSIS 132



    This table of content is tentative and subject to change as the research progresses.

    Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.